Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 502 results for "atorvastatin"

EASY-FIT: High-dose atorvastatin provided increase in fibrous ...

In the EASY-FIT study, atorvastatin 20 mg per day provided a greater increase in fibrous cap thickness in coronary atherosclerotic plaques at 12 months than atorvastatin 5 mg per day. Kenichi Komukai, MD, and colleagues assessed the effect of ... Orthopedics Today, 1 week ago

15 images for atorvastatin

RT Magazine, 1 week ago
MDLinx, 1 day ago
MDLinx, 1 day ago
MDLinx, 1 day ago
MDLinx, 1 day ago
MDLinx, 2 weeks ago
MDLinx, 2 weeks ago
MDLinx, 2 weeks ago
Toronto Star Online, 2 months ago
Citytv, 2 months ago

Atorvastatin at Reperfusion Reduces Myocardial Infarct Size in Mice by Activating eNOS in Bone Marrow-Derived Cells

by Yikui Tian, Joel Linden, Brent A. French, Zequan Yang Background The current study was designed to test our hypothesis that atorvastatin could reduce infarct size in intact mice by activating eNOS, specifically the eNOS in bone marrow-derived ...
 Plosone.org2 weeks ago

Studies from Shanghai Jiao-Tong University Have Provided New Information about Clinical Trials and Studies [Effects of atorvastatin on bone mineral...

Studies from Shanghai Jiao-Tong University Have Provided New Information about Clinical Trials and Studies [Effects of atorvastatin on bone mineral density (BMD) and bone metabolism in elderly males with osteopenia and mild dyslipidemia: A ...] ...
 4 Traders2 weeks ago

Assessment of hepatic function, oxidant/antioxidant status, and histopathological changes in rats treated with atorvastatin: Effect of dose and acute intoxication with acetaminophen

Effect of dose and acute intoxication with acetaminophen MM Farag 1 ⇑ MB Mohamed 1 EA Youssef 2 1 Department of Pharmacology, Medical Research Institute, Alexandria University, Alexandria, Egypt 2 Department of Cell Biology, Medical ...
 Human And Experimental Toxicology3 weeks ago

Effect of Atorvastatin Therapy on FibrousCap Thickness in Coronary Atherosclerotic Plaque as Assessed byOptical CoherenceTomography The EASY-FIT Study

Background The detailed mechanism of plaque stabilization by statin therapy is not fully understood. Objectives The aim of this study was to assess the effect of lipid-lowering therapy with 20 mg/day of atorvastatin versus 5 mg/day of atorvastatin ...
 Journal of the American College of Cardiology3 weeks ago

Comparison of the Efficacy of Rosuvastatin versus Atorvastatin in Preventing Contrast Induced Nephropathy in Patient with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention

by Yong Liu, Yuan-hui Liu, Ning Tan, Ji-yan Chen, Ying-ling Zhou, Li-wen Li, Chong-yang Duan, Ping-Yan Chen, Jian-fang Luo, Hua-long Li, Wei-Guo Objectives We prospectively compared the preventive effects of rosuvastatin and atorvastatin on ...
 Plosone.org1 month ago

Pooled RCTs: Atorvastatin did not increase renal-related serious adverse events

Terms of Use The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property ...
 Annals of Internal Medicine1 month ago

Good News: Vascepa Kept Its Place On National Formularies

Summary Vascepa stayed on the preferred lists of the top 3 PBMs (Express Scripts, CVS/Caremark, and Catamaran), despite the presence of Lovaza generics since April. About a third of the largest 25 insurers have Vascepa on their Medicare and state ...
 Seeking Alpha1 day ago
Daily Caller

Rise Of The Indian Drug Industry Demands Improved Regulation

4412758 A major Indian biotechnology company just announced it is breaking into the exciting field of biologic medicines. Zydus-Cadila has successfully manufactured a rough copy of a popular autoimmune disease biologic called Humira. The firm has ...
 Daily Caller1 day ago

Big pharma spent $112 billion on R&D in 2013

Despite an apparant hefty increase in R&D outlay, a number of large pharma firms also hauled back on clinical investment The top 30 pharma companies spent a combined total of $112 billion on research and development last year. Calculated to be ...
 Pharmafocus1 day ago Top 30 Pharmas spent $112 billion on R&D in 2013; report  Pharma Letter1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less